Table 1_Global, regional, and national esophageal cancer deaths and DALYs attributable to diet low in vegetables and fruits, 1990–2019: analysis for the global burden of disease st... حسب Bing Cui (179696)

"…From 1990 to 2019, while the absolute numbers of deaths and DALYs followed a complex trajectory of initial increase followed by decline, age-standardized rates consistently decreased, reflecting the positive impact of epidemiological improvements. …"

Chromatin accessibility profiling of Treg cells in acute urticaria حسب Leilei Wen (3551444)

"…The elevated expression of IL-1b may be due to the diminished immune-suppressive function following the decline of Tregs in this study. We found that <i>IL1B</i> gene expression was also significantly increased in the skin lesions of both chronic spontaneous urticaria and solar urticaria compared to healthy controls. …"

Table 1_Effect of simulated acidification on soil properties and plant nutrient uptake of eggplant in greenhouse.docx حسب Tianqi Wang (4093009)

"…Among the available nutrients, only potassium levels did not exhibit significant variation across treatments. However, the levels of macro elements in the soil consistently decreased, while the concentrations of trace elements (Fe, Cu, Zn) increased with rising acidity; conversely, the levels of other trace elements (B, Mo, Mn) decreased. …"

30-year trends in incidence of acute STEMI and NSTEMI in the Belgian Province of Luxembourg. A long-term follow-up of the MONICA-BELLUX registry حسب Bernhard L. Gerber (10171583)

"…</p><p>b) What this study adds</p><p>In a 30-year registry in Luxembourg using modern AMI definitions, overall, AMI incidence decreased significantly, primarily due to a 3.8-fold reduction in STEMI.…"

Experimental and Numerical Investigations of Soot Formation in the Laminar to Turbulent Transition of an Acetylene Diffusion Flame حسب Shijun Chen (835302)

"…Results from different regimes indicate the following: (1) In the laminar state, <i>ṁ</i>_soot increased linearly with <i>Re</i>, with a growth rate positively correlated with the tube diameter. (2) After entering the transitional state, <i>ṁ</i>_soot decreased exponentially by over 95%; <i>T</i> gradually increased by 150 K; and both SPL and the standard deviation of <i>T</i> (σ_<i>T</i>) initially rose and then declined. (3) After entering the fully turbulent state, SPL increased again whereas σ_<i>T</i> stabilized at 14. …"

Table 1_Effect of Ebenatide on glycemic metabolism and body fat in patients with type 2 diabetes mellitus.docx حسب Cheng-lan Xu (21562694)

"…Body composition analysis showed that the Ebenatide group had significant declines in weight, BMI, body fat and waist-to-height ratio (WHtR) (P<0.05). …"

Sexual behaviour, contraceptive use, and family planning intentions: 30 years of repeated cross-sectional surveys حسب Cerisa Obern (20826271)

"…The use of SARC (<i>p</i> = <0.01) and LARC (<i>p</i> = 0.04) has increased since 2014, while condom use and emergency contraceptive use have decreased (<i>p</i> = <0.01 for both). Three out of four respondents (<i>n</i> = 449) wanted children, significantly fewer than 2014.…"

Data Sheet 1_Fatty acid metabolism after short-term fasting: POMC response and EPA signal maintain homeostasis in tilapia.zip حسب Xiaozheng Yu (8071307)

"…There was a significant increase in most long-chain fatty acids, excluding the EPA which declined. …"

Data Sheet 3_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"

Data Sheet 1_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"

Data Sheet 8_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"

Data Sheet 9_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"

Data Sheet 4_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"

Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"

Data Sheet 11_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"

Data Sheet 5_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"

Data Sheet 2_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"

Data Sheet 10_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"

Data Sheet 12_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"

Data Sheet 6_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... حسب Alessandro Colletta (1509928)

"…Over 48 months, GFR increased in the SGLT2i group (+13.5 ± 1.3) and declined in the insulin group (−4.2 ± 1.4; p < 0.01). …"